Search - tctmd.com

Displaying 421 - 440 of 447

Sort: Relevancy | Date

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

News Industry News

Late Breaking Clinical Trial Reveals Reduced Risk of Atrial Fibrillation for Patients with Medtronic Devices Featuring AdaptivCRT

September 23, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Industry News

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

June 24, 2013

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Industry News

Biventricular Pacing Reduces Symptoms and Improves Quality-of-Life in AV Block Patients with Heart Failure and Reduced Pumping Function

May 11, 2013

News Industry News

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

May 09, 2013

News Industry News

BIOTRONIK continues 50-year legacy of engineering excellence with smaller, thinner ICD/CRT-D, including the unique DX platform

May 08, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

News Industry News

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

April 09, 2013

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Industry News

CardioFocus Announces Largest Worldwide Study of HeartLight® EAS Acute Clinical Outcomes Presented at Heart Rhythm 2012

June 04, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

News Daily News

Un Documento de Consenso Perfila las Directrices para el Uso del Cateterismo Cardíaco

May 15, 2012

News Daily News

Consensus Document Outlines Guidelines for Cardiac Cath Use

May 15, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

Advertisement

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Experts Discuss Efficacy, Safety of Watchman Device

Late Breaking Clinical Trial Reveals Reduced Risk of Atrial Fibrillation for Patients with Medtronic Devices Featuring AdaptivCRT

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Biventricular Pacing Reduces Symptoms and Improves Quality-of-Life in AV Block Patients with Heart Failure and Reduced Pumping Function

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

BIOTRONIK continues 50-year legacy of engineering excellence with smaller, thinner ICD/CRT-D, including the unique DX platform

ESC Offers Recommendations on Use of New Oral Anticoagulants

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

CardioFocus Announces Largest Worldwide Study of HeartLight® EAS Acute Clinical Outcomes Presented at Heart Rhythm 2012

Watchman Works Just as Well Without Warfarin-Protected Transition

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Un Documento de Consenso Perfila las Directrices para el Uso del Cateterismo Cardíaco

Consensus Document Outlines Guidelines for Cardiac Cath Use

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content